Navigation Links
A Protein from Primate may Save Humans from HIV !

sity of California, Los Angeles, before he moved to UCF in 2003. Drs. Otto Yang and Robert Lehrer, infectious disease specialists at UCLA, and researchers at the University of Pittsburgh and Emory University are collaborating with Cole.

There are three classes of defensin peptides, and most research around the world has focused on alpha and beta defensins, the two types that humans still make. Cole studies theta-defensins called retrocyclins, which are no longer made by humans or advanced primates such as chimpanzees. However, theta-defensins are more active against HIV-1 than the other two types of defensins and can be developed in laboratories, two features that suggest retrocyclins still could become an effective way to fight the virus.

HIV-1 is the most common form of the human immunodeficiency virus that causes AIDS. The disease is often transmitted sexually, and the drugs produced from Cole's research would be applied to the vagina in the form of a gel or cream. Many of the laboratory tests have shown that retrocyclin can prevent HIV-1 infection of human vaginal tissue.

Retrocyclin was still an effective inhibitor of HIV-1 even after 100 days of continuous exposure to human cells in a laboratory setting. Cole and his team are encouraged that only minimal resistance of the virus occurred during that time. Higher resistance levels make it more difficult to develop drugs to fight the virus because doses must be increased substantially over time.

The exact reason why resistance does not develop quickly with retrocyclin is unclear, but it may be a result of retrocyclin interacting with more than one target on both the cell and virus. Viruses that have to defeat more than one antiviral mechanism often develop resistance at a much slower pace.

The next phase of Cole's research will delve more into the mutations that HIV-1 can take in an effort to minimize them as much as possible. Many series of laboratory tests would
'"/>




Page: 1 2 3

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
(Date:12/2/2008)...Newswire-FirstCall/ -- VirtualScopics, Inc.,(Nasd...maging for clinical,trials, today announced that ...d to $14.7 million at the same time a year ago, a ... backlog as the amount remaining to be,recognized...f the studies,included within the backlog ranges ...
(Date:12/2/2008)...t Finds Many Cite Prevention, Shedding, or Sharing...swire-USNewswire/ -- A New Center for State and Lo...es are balancing retiree health care plans and the...th Care in the American States examines how state... health care benefits to central human resources (...
(Date:12/2/2008)...nts treated with radiation prior to surgery for ad...r recurrence and better overall survival rates, ac...rt examined a treatment called neoadjuvant therapy...he spread of cancer, before surgery to remove the ...y and/or radiation. , Neoadjuvant therapy shoul...
(Date:12/2/2008)...port from the Institute of Medicine proposes revis...s to decrease the chances of fatigue-related medic...for these doctors in training. The report does no... from the maximum average of 80 per week set by th...tion (ACGME) in 2003, but rather reduces the maxim...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
... is common among older men. Being the second most ...cer, it is the second leading cause of cancer deat...tection there has been a increase in number of det...reening consists of digital rectal exam and a pros...
...HO's list that travelers should avoid because of S...fe place to live were stunned by this. Toronto is ...as a threat to international health because of the...e in China were also added to its list, which alre...
...in the UK most people believe that asthma is a con...of people with asthma develop the condition in adu... are not recognised and managed in early stages. A...ime at any age. There also exists a possibility wh...
...ound that an active lifestyle with limiting TV tim...survey conducted in the US TV watching results in ... like sewing, playing board games, reading, writin... linked to obesity in children. The health campaig...
Other Medicine News:
(Date:12/1/2008)...with Hypophosphatasia Treated With ENB-0040 at Chi...eg , , MONTREAL, Dec. 1 Eno...ocused on developing novel therapeutics for seriou...nfant patient in its clinical program for hypophos... Replacement Therapy (ERT) with ENB-0040 for the t...
(Date:12/1/2008)...ARD, Denmark, December 1 ...with the intent to procure an MVA-based,third ge...ment Services,Canada, on behalf of the Canadian D...ract to Bavarian Nordic for the delivery of IMVAMU... use IMVAMUNE(R) as part of the,country,s bio-pre...
(Date:11/30/2008)... CHICAGO, Dec. 1 Older...bral blood flow and a greater number of small bloo...ented today at the annual meeting of the Radiologi...he study, conducted at the University of North Ca...pare brain scans of older adults who exercise to b...
(Date:11/27/2008)...finds the majority of acute lymphoblastic leukemia...t the time of diagnosis , , MEMPHIS, Tenn.,...St. Jude Children,s Research Hospital have identif...s of children with acute lymphoblastic leukemia (A...ay to designing treatments for ALL relapse in chil...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 1First Lady Laura Bush Visits AED Netmark Malaria Control Project in Ghana 12394 2Sikka Software and Dental Economics Announce Alliance 12392 1Sikka Software and Dental Economics Announce Alliance 12392 2Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 1Yoga Journal Circulation Increases 5 8 Percent in Second Half of 2007 from Same Period Previous Year 12390 2Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 1Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 2Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 3Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 4Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 5Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 6Meadowbrook Insurance Group Inc and ProCentury Corporation Reach Agreement to Merge in 24272 6 Million Transaction 12388 7
...ther diagnostic regimes that were previously restr...lysis is entering the clinical mainstream. Smaller...fordable for hospital or large physicians group la...lable for primary point of care locations such as ... 310 Genetic Analyzer from Applied Biosystems, Fos...
...5, Chiron Corporation notified the CDC that none o...ble for distribution in the United States for the ...en removal of nearly half of the anticipated Ameri...ral public have grown increasingly alarmed about t...pidemic. , ,It remains to be seen if virulent ...
Other Medicine Technology:Genetic Analysis Systems Enter the Clinical Mainstream 2Genetic Analysis Systems Enter the Clinical Mainstream 3Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
...oped a range of Milli-Q ultrapure water systems de...s. Each of the five new Milli-Q systems is designe...to particular applications such as HPLC, molecular...h precision resistivity monitor that records condu...
Medicine Products: